Publication|Articles|April 18, 2025
- Pharmaceutical Executive: April 2025
- Volume 45
- Issue 3
Pharmaceutical Executive: April 2025 Interactive Digital Edition
View the Pharmaceutical Executive April 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
8 months ago
‘Earning’ Power8 months ago
Milan Kalawadia: Carving Out New Pathways8 months ago
Bringing Biotech Innovation Across Borders8 months ago
Using AI to Predict Launch Success8 months ago
The Future of DTC in PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor
2
JP Morgan 2026 Preview: Eli Lilly Seeks Bounce Back
3
Alnylam Announces $250 Million Investment in Massachusetts Facility
4
Pharmaceutical Executive Daily: Nine New Additions to TrumpRx
5
